N-acetylcysteine in Intra-amniotic Infection/Inflammation
Diseases and Conditions Researched
Chorioamnionitis; Infection; Inflammation; Labor, Premature; Preterm Premature Rupture of the Membranes
What is the purpose of this trial?
The aim of the study is to determine if N-acetylcysteine (a potent free radical scavenger) prevents the occurrence of adverse neonatal outcomes in preterm deliveries complicated by infection associated with preterm labor or preterm premature rupture of membranes (PPROM). The working hypothesis is that in pregnancies complicated by intra-amniotic infection or inflammation, N-acetylcysteine protects the fetus by preventing the development, or decreasing the intensity and/or progression of the fetal inflammatory syndrome.
Click here for detailed participation information for this trial.
|Dates:||November 7, 2006|
|Last Updated:||July 18, 2012|
How will my information be used?
When you express interest in a specific study, the information from your profile will be sent to the doctor conducting that study. If you're eligible to participate, you may be contacted by a nurse or study coordinator.
If you select a health category rather than a specific study, doctors who have active studies in that area may contact you to ask if you would like to participate.
In both cases, you will be contacted by the preferred method (email or phone) that you specified in your profile.